Geeta Jeevan Aurangabadkar*
Consultant Endocrinologist, Care hospital and Excell hospital, Hyderabad, India
*Address for Correspondence: Dr. Geeta Aurangabadkar, Excell hospital, Hyderabad, India, Email: vrgeeta@yahoo.com
Received: 25 August 2020; Accepted: 07 September 2020; Published: 08 September 2020
Citation of this article: Aurangabadkar G (2020) How do we ensure safety for patients and clinicians while utilising Telemedicine in the field of Diabetes. Rea Int J of End and Diabe. 1(1): 022-025. DOI: 10.37179/rijed.000006.
Telemedicine use has been at its highest for patients in recent times due to ongoing COVID 19 pandemics. Although avoidance of face to face consultations carries many advantages for both patients and clinicians, there are always concerns around safety and legal aspects. So, how do we assure that the way of using teleconsultation in the field of diabetes is a mutually safe, effective, and sustainable option in the long term? This article lays out some important solutions addressing underlying apprehension and barriers in the use of telemedicine for diabetes. This is obviously truly relevant in the current scenario of COVID 19 where we anticipate continued use of telemedicine in near future.
Keywords: COVID-19 (Coronavirus disease of 2019), Information technology (IT), Telemedicine in diabetes, Patient, and clinician safety.
Coming Soon...
Coming Soon...
Coming Soon...
Coming Soon...